Works matching IS 13518216 AND DT 2018 AND VI 24 AND IP 3

Results: 48

Diagnostic delay in acquired haemophilia: Analysis of causes and consequences in a 20‐year Spanish cohort.

Published in:

2018

By:

Pardos‐Gea, J.;
Fernández‐Díaz, N.;
Parra, R.;
Altisent, C.;
Cortina, V.

Publication type:

Letter to the Editor

The multiple benefits of sport in haemophilia.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 341, doi. 10.1111/hae.13496

By:

Farrugia, A.;
Gringeri, A.;
von Mackensen, S.

Publication type:

Article

Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 344, doi. 10.1111/hae.13495

By:

Collins, P. W.;
Hart, D. P.;
Liesner, R.;
Makris, M.;
Talks, K.;
Chowdary, P.;
Riddell, A.;
Chalmers, E.;
Hall, G.;
Percy, C. L.;
Hay, C. R.

Publication type:

Article

The interaction of factor V and tissue factor pathway inhibitor in a myeloma patient with acquired factor V deficiency.

Published in:

2018

By:

De Maertelaere, E.;
Van haute, I.;
Castoldi, E.;
Deeren, D.;
Devreese, K. M.

Publication type:

Letter to the Editor

Frequencies of intron 1 and 22 inversions of factor VIII gene: A first report in Afghan patients with severe haemophilia A.

Published in:

2018

By:

Mousavi, S. H.;
Mesbah‐Namin, S. A.;
Rezaie, N.;
Zeinali, S.

Publication type:

Letter to the Editor

Type 3 von Willebrand disease mistaken for moderate haemophilia A: a lesson still to be learned.

Published in:

2018

By:

Galletta, E.;
Daidone, V.;
Zanon, E.;
Casonato, S.

Publication type:

Letter to the Editor

Replacement therapy during surgery in von Willebrand disease needs personalization.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 338, doi. 10.1111/hae.13488

By:

Berntorp, E.

Publication type:

Article

DDAVP trial in discrepant non‐severe haemophilia A patients.

Published in:

2018

By:

Rollins‐Raval, M. A.;
Okoye, H. C.;
Nielsen, B. I.;
Key, N. S.;
Lee, K.;
Abajas, Y. L.

Publication type:

Letter to the Editor

Pharmacokinetic modelling and validation of the half‐life extension needed to reduce the burden of infusions compared with standard factor VIII.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 376, doi. 10.1111/hae.13483

By:

Hermans, C.;
Berntorp, E.;
Mahlangu, J.;
Booth, J.;
Schütz, H.;
Santagostino, E.;
Young, G.;
Lee, H.‐Y.;
Steinitz‐Trost, K. N.;
Blanchette, V.

Publication type:

Article

Management of pregnancy complications in type 2N von Willebrand disease associated to a novel mutation.

Published in:

2018

By:

Brennan, Y.;
Curnow, J.;
Favaloro, E. J.;
Curtin, J.

Publication type:

Letter to the Editor

Real life experiences of a PK dosing study—Challenges and lessons learned.

Published in:

2018

By:

Mangles, S.;
Rea, C.;
Needham, J.;
Rangarajan, S.;
Madan, B.;
Nielsen, E. I.;
Jönsson, S.;
Collins, P. W.

Publication type:

Letter to the Editor

Screening of haemophilia carriers in moderate and severe haemophilia A and B: Prevalence and determinants.

Published in:

2018

By:

Bernard, W.;
Lambert, C.;
Hermans, C.;
Henrard, S.

Publication type:

Letter to the Editor

Assessment of passive musculoarticular ankle stiffness in children, adolescents and young adults with haemophilic ankle arthropathy.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. e103, doi. 10.1111/hae.13467

By:

Cartiaux, O.;
Detrembleur, C.;
Lobet, S.;
Hermans, C.;
Peerlinck, K.;
Henrard, S.;
Deschamps, K.

Publication type:

Article

Successful treatment of acquired von Willebrand disease with lenalidomide leading to dramatic resolution of intractable gastrointestinal bleeding: A case report.

Published in:

2018

By:

Thomas, W.;
Warner, E.;
Symington, E.;
Cameron, E.

Publication type:

Letter to the Editor

Moderate and severe haemophilia in Spain: An epidemiological update.

Published in:

2018

By:

Aznar, J. A.;
Bonanad, S.;
Altisent, C.;
Álvarez‐Román, M. T.;
Mingot‐Castellano, M. E.;
López, M. F.

Publication type:

Letter to the Editor

Cost‐utility of a six‐month programmed sports therapy (PST) in patients with haemophilia.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 385, doi. 10.1111/hae.13459

By:

Koeberlein‐Neu, J.;
Runkel, B.;
Hilberg, T.

Publication type:

Article

Successful multi‐modal immune tolerance induction for factor IX deficiency with inhibitors and allergic reactions.

Published in:

2018

By:

Kuhn, J.;
Massey, G. V.;
Noda, C.

Publication type:

Letter to the Editor

Inheritance of von Willebrand disease Vicenza in a Japanese family.

Published in:

2018

By:

Shigekiyo, T.;
Udaka, K.;
Sekimoto, E.;
Shibata, H.;
Ozaki, S.;
Takeda, M.;
Aihara, K.

Publication type:

Letter to the Editor

Analysis of current perioperative management with Haemate<sup>®</sup> P/Humate P<sup>®</sup> in von Willebrand disease: Identifying the need for personalized treatment.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 460, doi. 10.1111/hae.13451

By:

the “OPTI‐CLOT" and “WIN" study group;
Hazendonk, H. C. A. M.;
Heijdra, J. M.;
Veerman, H. C.;
van Moort, I.;
Cnossen, M. H.;
de Jager, N. C. B.;
Mathôt, R. A. A.;
Boender, J.;
Leebeek, F. W. G.;
Meijer, K.;
Laros‐van Gorkom, B. A. P.;
Eikenboom, J.;
Fijnvandraat, K.

Publication type:

Article

Response: The coagulation laboratory monitoring of AFSTYLA single‐chain FVIII concentrate.

Published in:

2018

By:

Friedman, K. D.;
Powell, J. S.;
Bensen‐Kennedy, D.

Publication type:

Letter to the Editor

Management of haemophilia carriers around the time of their delivery: Phenotypic variation requiring customization of management.

Published in:

2018

By:

Girgis, M. R.;
Gusba, L.;
Kuriakose, P.

Publication type:

Letter to the Editor

Long‐term clinical and economic outcomes in previously untreated paediatric patients with severe haemophilia A: A nationwide real‐world study with 700 person‐years.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 436, doi. 10.1111/hae.13447

By:

Vepsäläinen, K.;
Riikonen, P.;
Lassila, R.;
Arola, M.;
Huttunen, P.;
Lähteenmäki, P.;
Möttönen, M.;
Selander, T.;
Martikainen, J.

Publication type:

Article

Evaluation of chromogenic factor IX assays by automated protocols.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 492, doi. 10.1111/hae.13446

By:

Dissanayake, K.;
Khoo, T.‐L.;
Kershaw, G. W.;
Chen, V. M.

Publication type:

Article

Effectiveness of the Medtep Hemophilia online platform for adherence to prophylactic treatment in haemophilia patients: Results from a 1‐year observational study.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 452, doi. 10.1111/hae.13444

By:

Cuesta‐Barriuso, R.;
López‐Pina, J. A.;
Nieto‐Munuera, J.;
Torres‐Ortuño, A.;
Sagarra‐Valls, G.;
Panisello‐Royo, J. M.

Publication type:

Article

A rare case of late development of inhibitor in haemophilia B with a complex course, and review of the literature.

Published in:

2018

By:

Soto, I.;
Martínez, D.;
Ávila, L. F.;
Bernardo, Á.

Publication type:

Letter to the Editor

Movement behaviour in adults with haemophilia compared to healthy adults.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 445, doi. 10.1111/hae.13441

By:

Schutgens, R. E. G.;
Timmer, M. A.;
de Kleijn, P.;
Veenhof, C.;
Pisters, M. F.;
de Bie, R. A.

Publication type:

Article

Physiotherapist inter‐rater reliability of the Haemophilia Early Arthropathy Detection with Ultrasound protocol.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 471, doi. 10.1111/hae.13440

By:

Stephensen, D.;
Patel, V.;
Classey, S.;
Harbidge, H.;
Taylor, S.;
Wells, A.

Publication type:

Article

Use of ultrasound for evaluation of painful joint episodes perceived as haemarthrosis in adult patients with severe haemophilia.

Published in:

2018

By:

Berro, M.;
Elichiry, M.;
Wasen, K.;
Insagaray, J.;
Rodríguez, I.

Publication type:

Letter to the Editor

Defining extended half‐life rFVIII—A critical review of the evidence.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 348, doi. 10.1111/hae.13438

By:

Mahlangu, J.;
Young, G.;
Hermans, C.;
Blanchette, V.;
Berntorp, E.;
Santagostino, E.

Publication type:

Article

The importance of ABO blood group in pharmacokinetic studies in haemophilia A.

Published in:

2018

By:

Franchini, M.;
Mengoli, C.;
Marano, G.;
Pupella, S.;
Liumbruno, G. M.;
Mannucci, P. M.

Publication type:

Letter to the Editor

Advantage of recombinant von Willebrand factor for peri‐operative management in paediatric acquired von Willebrand syndrome.

Published in:

2018

By:

Weyand, A. C.;
Pipe, S. W.;
Jesudas, R.

Publication type:

Letter to the Editor

Effects of pre‐analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 487, doi. 10.1111/hae.13435

By:

Boylan, B.;
Miller, C. H.

Publication type:

Article

Reagent substitutions in the Centers for Disease Control and Prevention Nijmegen‐Bethesda assay for factor VIII inhibitors.

Published in:

2018

By:

Miller, C. H.;
Payne, A. B.;
Driggers, J.;
Ellingsen, D.;
Boylan, B.;
Bean, C. J.

Publication type:

Letter to the Editor

Arteriovenous shunts as venous access in children with haemophilia.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 429, doi. 10.1111/hae.13433

By:

Thom, K. E.;
Male, C.;
Hölzenbein, T.;
Gattringer, S.;
Jones, N.;
Zwiauer, K.;
Streif, W.

Publication type:

Article

Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 414, doi. 10.1111/hae.13432

By:

Wang, C.;
Young, G.

Publication type:

Article

World bleeding disorders registry: The pilot study.

Published in:

2018

By:

Coffin, D.;
Herr, C.;
Pierce, G. F.;
O'Hara, J.;
Diop, S.;
Hollingsworth, R.;
Srivastava, A.;
Lillicrap, D.;
van den Berg, H. M.;
Iorio, A.

Publication type:

Letter to the Editor

In vitro characterization of MOD‐5014, a novel long‐acting carboxy‐terminal peptide (CTP)‐modified activated FVII.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 477, doi. 10.1111/hae.13428

By:

Bar‐Ilan, A.;
Hoffmann, M.;
Binder, L.;
Zakar, M.;
Guy, R.;
Felikman, Y.;
Moschcovich, L.;
Hershkovitz, O.;
Hart, G.;
Livnat, T.;
Shenkman, B.;
Kenet, G.;
Monroe, D.

Publication type:

Article

Principles of haemophilia care: The Asia‐Pacific perspective.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 366, doi. 10.1111/hae.13425

By:

the Asia‐Pacific Haemophilia Working Group (APHWG);
Dunkley, S.;
Srivastava, A.;
Lam, J. C. M.;
John, M. J.;
Wong, R. S. M.;
Tran, H.;
Yang, R.;
Nair, S. C.;
Shima, M.;
Street, A.

Publication type:

Article

High proportion of patients with bleeding of unknown cause in persons with a mild‐to‐moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB).

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 405, doi. 10.1111/hae.13422

By:

Hofer, S.;
Kepa, S.;
Kyrle, P. A.;
Eichinger, S.;
Knöbl, P.;
Eischer, L.;
Ay, C.;
Pabinger, I.;
Panzer, S.;
Quehenberger, P.;
Sunder‐Plassmann, R.;
Hoermann, G.;
Haslacher, H.;
Mannhalter, C.;
Eigenbauer, E.;
Gebhart, J.

Publication type:

Article

Clinical trials and registries in haemophilia: Opponents or collaborators? Comparison of PUP data derived from different data sources.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 420, doi. 10.1111/hae.13421

By:

Keipert, C.;
Hilger, A.;
Jonker, C. J.;
van den Berg, H. M.

Publication type:

Article

Male gender, school attendance and sports participation are positively associated with health‐related quality of life in children and adolescents with congenital bleeding disorders.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 395, doi. 10.1111/hae.13420

By:

Limperg, P. F.;
Joosten, M. M. H.;
Grootenhuis, M. A.;
Haverman, L.;
Fijnvandraat, K.;
Peters, M.

Publication type:

Article

Ligneous cervicitis and endometritis: A gynaecological presentation of congenital plasminogen deficiency.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 359, doi. 10.1111/hae.13418

By:

Baithun, M.;
Kadir, R. A.;
Freeman‐Wang, T.;
Chowdary, P.

Publication type:

Article

Point‐of‐care ultrasonography in haemophilia care: Training and competency for muscular haematomas.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. 335, doi. 10.1111/hae.13417

By:

Strike, K.;
Uy, M.;
Lawson, W.;
Squire, S.;
Jackson, S.;
Iorio, A.;
Stein, N.;
Chan, A.

Publication type:

Article

Burden of illness and costs among paediatric haemophilia patients with and without central venous access devices treated in US hospitals.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. e93, doi. 10.1111/hae.13404

By:

Buckley, B.;
Prasad, M.;
Kendter, J.;
Hall, II, E.;
Dreyfus, J.;
Gayle, J.

Publication type:

Article

Real‐world experience with use of Antihemophilic Factor (Recombinant), PEGylated for prophylaxis in severe haemophilia A.

Published in:

Haemophilia, 2018, v. 24, n. 3, p. e84, doi. 10.1111/hae.13403

By:

Dunn, A. L.;
Ahuja, S. P.;
Mullins, E. S.

Publication type:

Article

Issue Information.

Published in:: Haemophilia, 2018, v. 24, n. 3, p. 329, doi. 10.1111/hae.13337
Publication type:: Article

Instructions for Authors.

Published in:: Haemophilia, 2018, v. 24, n. 3, p. 504, doi. 10.1111/hae.13336
Publication type:: Article

Retracted: National home infusion teaching guidelines will improve quality of care and patient outcomes in haemophilia treatment centres across the USA.

Published in:

2018

By:

Santaella, M. E.;
Bloomberg, M. C.;
Anglade, D.

Publication type:

Letter to the Editor